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High-throughput crystallographic approaches require integrated software
solutions to minimize the need for manual effort. REdiii is a system that allows
fully automated crystallographic structure solution by integrating existing
crystallographic software into an adaptive and partly autonomous workflow
engine. The program can be initiated after collecting the first frame of diffraction
data and is able to perform processing, molecular-replacement phasing, chain
tracing, ligand fitting and refinement without further user intervention. Preset
values for each software component allow efficient progress with high-quality
data and known parameters. The adaptive workflow engine can determine
whether some parameters require modifications and choose alternative software
strategies in case the preconfigured solution is inadequate. This integrated
pipeline is targeted at providing a comprehensive and efficient approach to
screening for ligand-bound co-crystal structures while minimizing repetitiveness
and allowing a high-throughput scientific discovery process.
1. Introduction
1.1. Automation in bio-crystallography
Automation of processes in biological research aids in
accelerating the scientific discovery process and allows the
efficient allocation of resources. Macromolecular crystallo-
graphy, in particular, has seen tremendous and rapid advances
in method automation from the use of robotics in experi-
mental setup and handling to image analysis while monitoring
crystal growth and data processing and model-building solu-
tions.
1.2. High-throughput crystallography during drug discovery
Especially during the drug-discovery process, crystallo-
graphy is an essential tool to gain insights into the structural
characteristics of drug candidates, their targets and the
determinants for effective interactions between them. Posi-
tional information with near-atomic resolution has proven to
be invaluable for developing specific and reliable therapeutics
and has led to modern structure-based drug design (Amzel,
1998).
In cases where obtaining well diffracting crystals of the
target protein is no longer the rate-limiting step, but efforts
are directed at screening libraries of known binders for co-
crystal structures, solving up to hundreds of crystallographic
data sets becomes a necessity. Excellent software solutions for
data processing, phasing, model building and ligand fitting are
available, but they do not readily fall into one comprehensive
pipeline.
1.3. Current state of automated pipelines
There are existing solutions that attempt to combine
the different steps and solve parts of the crystallographic
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structure-determination pipeline once data have been
collected, including ACrs (Brunzelle et al., 2003), ELVES
(Holton & Alber, 2004) and SGXpro (Fu et al., 2005). Similar
proprietary solutions developed for structural genomics
consortia (Rupp et al., 2002) and Auto-Rickshaw (Panjikar et
al., 2005) were designed for experimental phasing but also
allow molecular replacement. The autoSHARP software
(Vonrhein et al., 2007) allows direct phasing starting from
merged data followed by automatic model building by calling
ARP/wARP (Langer et al., 2008). Also, the widely used HKL-
3000 (Minor et al., 2006) automates individual steps of struc-
ture solution and provides extensive feedback and user
control. However, a fully automated pipeline is required
for high-throughput crystallography. A recent development,
phenix.ligand_pipeline (Echols et al., 2014), allows molecular
replacement phasing of merged data followed by a refinement
and/or model-building round with AutoBuild allowing subse-
quent ligand placement using phenix.ligandfit, all in an auto-
mated manner without requiring additional user input during
the process.
Although all of these approaches combine existing software
into a pipeline with reduced user intervention, and the term
‘automated structure-determination pipeline’ has been used
to describe software that perform data manipulation and
decision-making during the structure-solution process, most of
these software solutions still require the user to learn how to
interact with a new software package without knowing how
well its design suits the question that the user is asking. The
automated structure-determination pipeline described here
will only require user intervention once, immediately after
initialization of data collection, and will perform all required
data manipulation from transfer of the first frame of diffrac-
tion data to refinement of ligand-bound structural models.
1.4. Necessity of fully automated structure solution
Co-crystallization trials often lead to an abundance of
crystals composed of the unliganded protein, and only the
complete process of diffracting the crystal, collecting an entire
data set, finding a solution and subsequent refinement reveals
the crystal composition. To computationally streamline this
process, automated software can determine the status of data
collection, prepare a search model of the protein, process the
data, perform MR phasing, generate solvent and refine the
solution. The crystallographer can then determine whether the
co-crystallization trial was successful, eliminating the need
to manually iterate through the entire procedure for many
crystals. Software specifically designed for searching for a
bound ligand, for example, can place a large emphasis on
speed, with accuracy and completeness not inevitably as
crucial (Dauter, 2010). For example, the Dimple software
(Wojdyr et al., 2014) allows the quick location of potential
ligands by comparing maps derived from putatively ligand-
bound structures with the corresponding apo structure. No
fully automated solution can be adapted to all experimental
needs, therefore certain drawbacks are inevitable since certain
aspects of the data and model may be unknown at the
beginning of the experiment. phenix.ligand_pipeline can
produce ligand-bound solutions of spectacular quality in a
very short time and even provides an automatically generated
Coot session for convenient access to the results. This pipeline
has to rely on the user to provide merged data and large
differences between the search model and the target structure,
such as domain movements that may accompany ligand
binding, can lead to failure. With REdiii, we attempt to
introduce steps of automated troubleshooting and generation
of a software ‘memory’ to overcome some of the obstacles
encountered by complete automation. The test cases
presented here were all processed with minimal information
and no user intervention. The lack of intervention can be
especially useful when working with large amounts of similar
data, but challenges remain. Sacrificing control by the user has
significant drawbacks in validating achieved results, especially
at intermediate steps. REdiii currently only incorporates tools
for molecular-replacement phasing, can run into issues with
highly mosaic data and does not check for twinned data.
Twinned data can be difficult when determining whether a
ligand can be fitted versus how many copies of the ligand are
present. Since REdiii will be an open-source tool with simple
code structures, significant improvements will happen over
time.
1.5. Introducing an automated structure-solution pipeline
Our solution streamlines commonly used software tools,
following well established methodologies, to mimic the
process of manual data processing and structure solution to
yield high-quality structural models without requiring addi-
tional manual manipulation. This approach can be used to
screen data of modest resolution for protein–ligand complexes
with reasonable results or to achieve very high-throughput
and high-quality models with good data. This software
solution can replace conventional user-guided processing and
model building, which can be extremely useful in all scenarios
where high throughput is needed. In addition to the require-
ments posed by this task, we aspired to design a workflow that
would satisfy a few additional constraints for functional
design: user input should only be required once, when crys-
tallographic diffraction data acquisition is initiated. Besides
raw data, any file containing computationally modified data
(e.g. .mtz, .pdb and .fasta files) can either be generated by
REdiii or be provided by the user, allowing the user to enter
or leave the REdiii workflow at any given point and also
permitting the user the flexibility to interface REdiii with
other software if so desired. REdiii should not only perform
tasks but also initiate automated troubleshooting of common
errors, generating a memory of successful runs and learning
project-specific parameters that have proven to be successful.
2. Methodology
REdiii, a completely automated tool that integrates excellent
software solutions for the individual steps of the crystallo-
graphic structure-solution process into a pipeline with
research papers
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additional layers of decision-making, has been developed (see
Fig. 1). Written in the Ruby programming language, REdiii
is platform-independent but is best suited to Unix-based
systems. Being user-friendly presupposes being flexible and
adaptive to individual needs; therefore, an approach in which
multiple tools are combined and little user input is required
was chosen. The software architecture allows swapping or
appending modules, easily allowing adaptability while main-
taining full automation during individual experiments.
2.1. User interface
The premise was to require interfacing between the user
and the software only once and at the beginning of data
collection, at which stage the knowledge of some parameters
may be limited. Decisions such as the resolution limit and the
composition of the asymmetric unit are left to the software;
however, the user is always informed about the progress at
the above-mentioned stages and software-decided parameters,
allowing the user to monitor the whole process. A command-
line interface allows the configuration of all necessary para-
meters in a single command and facilitates server-based or
remote access. For more interactive use, a graphical interface
provides a form with preconfigured project or user-specific
presets (see Fig. 2). After the successful completion of each
key task described above, REdiii can send notifications and
statistical parameters via email. The quality of each solution
has to be assessed by the user. Different quality indicators,
such as the Rmeas value in the highest resolution shell or the
overall completeness, can be input to the software as para-
meters, and the software will report the statistics table
generated by xia2, the RFZ and TFZ scores after molecular
replacement and R/Rfree after completing chain tracing and
ligand fitting, as well as an overall statistics table. However,
the software will not autonomously decide whether the
solution is final and adequate or whether further refinement
is required. REdiii will only change parameters that were
specified by the user if the crystallographic software that has
been called for the specific task reports a failure.
2.2. Architecture
The Ruby programming language was chosen to implement
the REdiii concepts because of its ease of reading syntax,
strong metaprogramming (Aerts & Law, 2009) and an abun-
dance of libraries providing bioinformatics (Goto et al., 2010),
process-management and web-framework tools. An option
parser reads the provided parameters for each run into vari-
ables. A search model can be generated by providing a PDB
code and chain identifiers, in which case the software will
generate a ligand-free and solvent-free model using PyMOL
(DeLano, 2002). In this case, a PyMOL script is written and
executed to fetch the .pdb file, strip solvent and ligands and
save the coordinates and sequence of the desired chain iden-
tifier to a .pdb and a .fasta file, respectively.
After each step during structure solution REdiii will check
whether the called crystallographic tool ran successfully, but
will generally not validate the quality of the result with the
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Figure 1
Workflow of macromolecular structure determination using REdiii. (a)
The operations depicted in green boxes are required to be performed
manually; the fully automated REdiii pipeline is depicted with blue boxes.
(b) Layered architecture of REdiii. Besides following several predefined
pathways to find a suitable solution, REdiii can recruit tools to actively
manipulate parameters and rerun select processes when necessary
(details are given in Fig. 3a). The blue layer represents the available set
of crystallographic tools on top of which decisions regarding the
composition of the asymmetric unit, the search model can be made,
influencing the chosen pathway. A database in which details about
successful solutions are being saved can also be queried for parameters
(red layer).
exception of completeness, resolution or, for example, Rmeas
cutoffs after data processing. Failure to generate valid output
files will trigger the pursuit of alternative options (see also
Fig. 3a for the decision-making process).
During a typical experiment, the main script of REdiii will
call relevant crystallographic software to accomplish the
following tasks (Fig. 1a). For processing raw diffraction data
frames, only one tool is allowed owing to the strong influence
of data quality on different processing strategies. xia2 (Winter,
2010), an expert system for data processing, allows sophisti-
cated parameterization and workflow automation of indexing,
integration and scaling. In REdiii, xia2 is mainly used to
provide an easily configurable interface with XDS (Kabsch,
2010), allowing automated indexing, integration and scaling.
xia2 was also chosen as the default tool for full automation
as it performs well in determining the space group if it is
unknown to the user and will likely choose the highest
symmetry space group that is in agreement with the unit-cell
parameters. Alternatively, the user can specify the space
group. As data quality can vary, in order to be able to work
with low-quality data while screening crystals, REdiii provides
interfaces to iMosflm and HKL-2000/3000 and then allows a
choice between widely used processing suites within the same
framework. The modular architecture of REdiii also directly
accepts the .sca files generated by HKL-2000/3000 and any
.mtz file containing Rfree flags, allowing complete user control
over the data processing. In this case, UNIQUEIFY,
CTRUNCATE and SCALEPACK2MTZ from the CCP4
program suite (Winn et al., 2011) are called separately to
generate the structure-factor file. At this stage, the output
.log file is parsed for statistical parameters and the user is
notified. Depending on previous knowledge of the structure,
the molecular-replacement pipelines AutoMR from the
PHENIX suite (Zwart et al., 2008) or BALBES (Long et al.,
2008) are used to solve the phase problem. The default
settings generate an AutoMR session for molecular-replace-
ment phasing, but BALBES is provided as an alternative
option. REdiii supports three options for model building and
explicit solvent generation: AutoBuild from the PHENIX
suite, Buccaneer (Cowtan, 2006) and ARP/wARP (Langer et
al., 2008). By default, chain tracing and water picking are
conducted using AutoBuild with the molecular-replacement
solution as the starting model and the PyMOL-generated
.fasta sequence as a target. The approach of building against
the original input sequence also allows the completion of
structural fragments that become visible only after molecular
replacement with BALBES. These regions of unfitted density
can lead to falsely attributed binding sites in the ligand-fitting
stage. Alternatively, Buccaneer or the auto_tracing.sh and
auto_solvent.sh scripts from the ARP/wARP suite can be
called. In the case of the latter, PyMOL is invoked to perform
chain splitting and dummy-atom replacement before and after
the ARP/wARP operations.
Subsequent to rebuilding, ligand-fitting steps can be
performed using ReadySet, eLBOW (the electronic Ligand
Builder and Optimization Workbench) and LigandFit from the
PHENIX suite with additional refinement cycles of the ligand-
bound complex using phenix.refine. If a .pdb file containing
ligand coordinates has been specified, phenix.elbow is invoked
to prepare geometry restraints for the ligand and phenix.
ligandfit is used for subsequent ligand placement. Another
PyMOL script is written and executed to generate a single
coordinate file containing the fitted ligand with a separate
chain identifier, which is refined by calling phenix.refine to
generate the final model and the corresponding statistics to
conclude the structure solution. The quality of the resulting
model and especially ligand placement has to be assessed by
the user and typically requires a resolution of 2 A˚ or better.
This linear workflow allows a decision to be made between the
18 possible pathways of model generation which result from
combinations of the available processing, phasing and model-
building tools (Fig. 3).
2.3. Automated troubleshooting
In some cases not all parameters are known at the begin-
ning of the experiment, but have to be estimated and can only
research papers
1062 Bohn & Schiffer  REdiii Acta Cryst. (2015). D71, 1059–1067
Figure 2
A basic graphical user interface. Based on the cross-platform GTK+
toolkit, the interface allows easy manipulation of a set of parameters. The
parameters accessible to the user are hardcoded into the software and can
be changed to allow different project-specific or user-specific interfaces.
The interface shown here depicts presets for the APOBEC3F C-terminal
domain, the default tools for processing, molecular replacement and
chain tracing with completeness and Rmeas as variable cutoff criteria
during processing.
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be determined at a later stage. To address this problem, REdiii
operates on a second layer of tools working on top of the
collection of linear pathways to actively manipulate para-
meters in the case that the user-defined input does not lead to
a successful solution (see Fig. 1). While REdiii is not capable
of performing true validation after each step, it can realise
whether a process finished successfully and pursue alternative
strategies in case of failure. A typical scenario involves input
of a wrong unit-cell composition, where correct identification
requires information that may not yet be available during data
collection. BALBES was included to resolve this potential
problem, as a molecular-replacement tool that does not
require the input of molecular weight and copy number, and
can automatically determine composition of the asymmetric
unit. REdiii will automatically use BALBES to determine the
composition of the asymmetric unit if molecular replacement
fails and the user had chosen AutoMR, and will rerun the
initial setup with the new parameters while informing the user
about the change in strategy (Fig. 1b, green layer). If mole-
cular replacement still fails, the protein database RESTful
web services are queried using the search-model sequence to
generate an ensemble of up to ten alternative search models
from similar available deposited structures. Subsequently,
Figure 3
Overview of the workflow and class architecture. (a) The points of
decision-making during an experiment. The workflow can be divided
into three types of pathways: the unadjusted default (red), automatic
rerouting in the case where the default fails (green) and optional user-
configurable routes (blue). (b) The architecture of individual classes
being called. PyMOL, class_logfile and class_message are called at
multiple stages when the model needs to be modified or output
information for the user is being prepared. PyMOL, iMosflm and
HKL-2000 are either called directly by the user or through separate
scripts (highlighted in green boxes).
molecular replacement can iterate through the alternative
models until a solution can be found or this step is considered
a failure.
Another common problem is a wrong initial space group.
Existing suites for data processing, including those used here,
exhibit a strong bias towards high-symmetry space groups
during indexing. This problem will often require manual
intervention and data-quality assessment. At the end of each
successful experiment, REdiii writes core parameters into a
database file (Fig. 1b, purple layer), allowing REdiii to later
query for entries of the same project group and using a multi-
layered perceptron to determine which space groups might be
worth trying to rerun the task with altered parameters. The
database setup is specific to each installation and comprises a
plain-text file of successful parameters for project-specific
experiments. Currently, REdiii is capable of retrieving space-
group information from previous experiments and initially
trying to re-index the data using these settings.
3. Results
REdiii has been tested with unpublished data from six
different proteins in apo forms and two data sets with ligand or
inhibitor bound to the protein to validate different aspects
of typical usage scenarios. Test cases span a resolution range
from 1.1 to 3.1 A˚. Each test case has been processed and
solved with the default settings and the minimum amount of
additional information, which consists of a search-model PDB
code, mass, space group and, in ligand-bound examples, a .pdb
file containing coordinates of the ligand geometry. The vali-
dated aspects and the outcomes for each test case are given in
Table 1, where different data sets were used to evaluate the
performance of REdiii. Table 2 lists the results for these test
cases using full automation and default settings and the
corresponding statistics. Being designed primarily for the
screening of crystals of putatively ligand-bound proteins, two
cases were chosen to validate performance in the most
common scenarios: a protein bound to a peptide ligand and a
protein bound to a small-molecule inhibitor. In addition to
novel data, 20 test cases of published data were chosen to
validate the reliability of the tool and allow comparison with
manual structure solutions. Table 3 shows the results of ten
different inhibitor-bound structures of HIV-1 protease and
Table 4 shows the corresponding results for inhibitor-bound
Hepatitis C virus protease.
Structures of APOBEC3F, Dengue virus protease, hemo-
globin, Hepatitis C virus (HCV) protease and APOBEC3G
were processed to resolutions between 1.14 and 3.05 A˚. The
resolution cutoff was determined automatically, with Rmeas in
the highest resolution shell being required to be below 0.4.
The R and Rfree values of the final models range between 0.18
and 0.24 and between 0.21 and 0.32, respectively. Ligand-
bound cases were solved to 1.8 and 2.1 A˚ resolution with
R/Rfree values of 0.22/0.26 and 0.34/0.39, respectively. CPU
time on standard workstations was 1.5–6 h, with mosaic and
twinned data being correlated with longer running times.
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Table 1
Aspects and outcomes of experimental test cases.
Cases were chosen to cover different aspects of typical usage scenarios to test the performance of REdiii. The cases span a resolution range from 1.14 to 3.05 A˚ and
include peptide and small-molecule ligand-bound protein structures.
Test case
Resolution
(A˚)
Space
group Aspect to be validated Outcome
A3F 1 2.58 P1 Ability to solve the apo structure of APOBEC3F, a
prerequisite for ligand screening during later co-
crystallization attempts
Solution has reasonable statistical parameters (see Table 2a);
the resulting model is identical to the published structure
(PDB entry 4iou)
A3F 2 3.05 P1 Ability to handle data sets from non-ideal diffracting crystals
for future optimization
Unit-cell parameters could not be refined without user
intervention and HKL-2000, mosaicity and lower resolu-
tion data became apparent in the refinement statistics
A3G 2.53 P1211 Another APOBEC3 family member to show that solutions
are model-independent and their quality is solely
determined by diffraction data
Refinement statistics are similar to the first test case and
provide proof that the quality of the obtained solutions is
model-independent
Dengue virus
protease
2.07 C2221 Processing synchrotron-quality data High-quality model was obtained within less than 2 h
computation time on a desktop workstation; refinement
parameters are not improved further by manual model
building
Hemoglobin 1.14 C121 High-resolution data from a rotating-anode generator as an
example of data obtained from well diffracting crystals
using a home source
The search model differs at three residues, which becomes
apparent in the refinement statistics; at this resolution the
differences are resolved to almost atomic detail, which
would be ideal for determining differences between a
bound and an unbound state (the typical REdiii scenario)
HCV protease 1.52 P1211 Comparing an apo with an inhibitor-bound form of the same
enzyme, in this case NS3/4A Hepatitis C virus (HCV)
protease
Statistical parameters show that the solution does not require
manual corrections; the obtained model was used as the
search model in the inhibitor-bound case
Inhibitor 1.84 P212121 HCV protease bound to a covalent inhibitor, demonstrating
the reliability of the automated ligand fitting
Processing, model building and fitting of the small molecule
work seamlessly and lead to good refinement statistics (see
Table 2b)
Substrate 2.09 P212121 HIV-1 protease bound to a peptide substrate as a test case for
docking of peptide moieties
Particularly difficult data set derived from a heavily quasi-
merohedrally twinned crystal; despite showing the worst
refinement statistics among all test cases, the model is
interpretable and the ligand was fitted correctly
In most test cases, solutions with acceptable R and Rfree
values were obtained with default settings and no user inter-
vention. Resolution and data quality (i.e. mosaicity and
twinning) appear to be limiting factors for the quality of
the REdiii-generated structure, as seen for the A3F 2 and
substrate-bound test cases. A3F 2 required the manual
exclusion of highly mosaic frames. The ligand position in the
substrate-bound test case was identified correctly, but crystal
twinning led to unsatisfyingly high R values for the resulting
model. Nevertheless, all unliganded structures from crystals
diffracting to beyond 3 A˚ were solved without requiring any
manual intervention, and the ligand-binding site was
successfully identified in all liganded structures. The test cases
from published structures show that data were usually
processed to higher resolution than those deposited (a deci-
sion made by xia2 during indexing), with R/Rfree values usually
within a few percentage points of the published values.
4. Discussion
We have described a computational pipeline that automates
the process of solving protein structures from crystallographic
data. Sets of diffraction data for a variety of proteins with
varying data quality and resolution were used to test the
performance of REdiii and its applicability to different
scenarios. In all cases, including the liganded structures, a
satisfactory solution was found without the need for any
intervention, except when the mosaicity was very high. As may
be anticipated, resolution, mosaicity and twinning are limiting
factors to the quality of the structure model generated.
However, with twinned data a single round of refinement
applying the twin law is usually sufficient to resolve issues.
Even though unliganded data at 3.0 A˚ resolution could be
treated well, ligand placement is more restricted, especially
with small molecules that can be easily misfitted into noise.
The test cases show that a resolution of 2.0 A˚ or higher is
desirable.
Building upon previous pipelines mentioned earlier, we
show that complete automation of the structure-solution
process with current tools is now possible. The commercially
research papers
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Table 2
Crystallographic statistics for test cases in Table 1.
Statistical parameters that were not generated because HKL-2000 was used
for processing are marked with an asterisk. The HIV protease–substrate
complex solution has higher R/Rfree values than expected for a correct solution
at this resolution, but the data set contained a significant fraction of twinned
data. Despite not accounting for twinning, the solution itself contains the
ligand placed correctly in the binding site. Statistics were calculated using xia2,
HKL-2000, phenix.refine and phenix.model_vs_data. Ramachandran quality,
rotamer quality and clashscore were calculated using phenix.table_one. R.m.s.
deviations were constructed using the bond and angle parameters of Engh &
Huber (1991).
(a) Unliganded data sets.
A3F 1 A3F 2 DEN Hemoglobin
HCV
protease A3G
Resolution (high) (A˚) 2.58 3.05 2.07 1.14 1.52 2.53
Resolution (low) (A˚) 32.12 25.84 28.58 29.72 33.24 29.49
Temperature (C) 180 180 180 180 180 180
Space group P1 P1 C2221 C121 P1211 P1211
Unit-cell parameters
a (A˚) 51.86 51.81 60.33 93.15 54.67 61.63
b (A˚) 68.75 67.61 61.60 43.29 58.44 67.96
c (A˚) 75.52 75.18 114.22 82.27 59.94 63.58
 () 110.32 110.22 90 90 90 90
 () 93.99 94.11 90 122.39 90.06 111.02
 () 110.83 110.46 90 90 90 90
Molecules in
asymmetric unit
4 4 1 2 2 2
Completeness (%) 84.6 84.7 98.9 87.8 99.5 97.9
Total reflections 46734 414472 97808 260408 246459 68583
Unique reflections 23717 14546 13188 88726 57676 16151
Mean I/(I) 12.9 18.8 10.8 14.5 15.7 17.7
Average multiplicity 2.0 1.6 7.4 2.9 4.3 4.2
Rmerge 0.056 0.122 0.155 0.038 0.051 0.065
Rmeas 0.079 * 0.167 0.044 0.059 0.075
Rp.i.m. 0.056 * 0.059 0.022 0.028 0.036
CC* 0.995 * 0.994 0.999 0.999 0.996
Wilson B factor (A˚2) 35 32 24 8 11 22
R.m.s. deviations from ideal values
Bonds (A˚) 0.01 0.01 0.01 0.01 0.01 0.01
Angles () 1.44 1.40 1.08 1.36 1.28 1.26
Average B factor (A˚2) 30 34 26 13 17 12
Ramachandran plot (%)
Favored 94 90 97 98 98 95
Allowed 6 7 3 2 1 5
Outliers 0 3 0 0 1 0
Rotamer outliers 8 14 3 2 2 4
Clashscore 9 16 4 15 9 9
R factor 0.23 0.23 0.18 0.22 0.20 0.24
Rfree 0.26 0.32 0.22 0.22 0.21 0.30
(b) Complexes between protein and a ligand.
HCV protease
+ inhibitor
HIV-1 protease
+ substrate
Resolution (high) (A˚) 1.84 2.09
Resolution (low) (A˚) 19.22 27.18
Temperature (C) 180 180
Space group P212121 P212121
Unit-cell parameters
a (A˚) 55.41 51.36
b (A˚) 58.99 60.70
c (A˚) 59.82 60.80
 () 90 90
 () 90 90
 () 90 90
Molecules in asymmetric unit 1 1
Completeness (%) 90.8 97.6
Total reflections 48641 41261
Unique reflections 15757 11452
Mean I/(I) 22.83 10.5
Average multiplicity 3.1 3.6
Rmerge 0.032 0.083
Rmeas 0.037 0.097
Rp.i.m. 0.019 0.048
CC* 0.999 0.995
Wilson B factor (A˚2) 10 25
R.m.s. deviations from ideal values
Bonds (A˚) 0.02 0.01
Angles () 2.91 1.60
Average B factor (A˚2) 12 28
Ramachandran plot
Favored 98 98
Allowed 2 1
Outliers 0 1
Rotamer outliers 3 9
Clashscore 10 22
R factor 0.22 0.35
Rfree 0.26 0.40
Table 2 (continued)
available HKL-3000 suite (Minor et al., 2006), for example,
allows highly automated molecular replacement and model
building using MOLREP and ARP/wARP or Buccaneer,
respectively.HKL-3000 has a very intuitive graphical interface
for these tools, but does not work autonomously and does not
provide automatization beyond what is inherent to those tools,
which is very different from fully automized software such as
phenix.ligand_pipeline or REdiii. HKL-3000 is also limited to
utilizing a single software solution for molecular replacement
and phasing, which is not ideal in scenarios where high
throughput is critical, but leads to stellar results especially
during indexing because of the vast amount of feedback
provided to the user. Because of this, solutions such as HKL-
3000 are at the other end of the spectrum where the user is
involved in and during every step to provide as much control
as possible. Another solution, the Auto-Rickshaw web server,
requires scaled and merged .mtz files with Rfree flags and can
perform molecular replacement and model building without
requiring user input, but does not incorporate ligand fitting.
However, ligand placement is critical to many crystal
screening efforts and the software is proprietary, which does
not allow the tool to be refitted to different experimental
needs.
Placement of ligands in REdiii does still require a .pdb file
with reliable ligand coordinates and chemically sound
restraints to obtain good geometry of the ligand in the
protein–ligand complex, as in most cases X-ray data alone will
not lead to reasonable convergence (Evans, 2007). A number
of solutions are available to facilitate the process of generating
chemically plausible models (Kleywegt, 2007), but the process
most often relies on precalculated restraints from accessible
databases. Ab initio calculations using quantum mechanics
are not feasible when high throughput is desired as they are
computationally intensive. The ligand preparation and fitting
tools within the PHENIX suite appear to be the most efficient
and reliable way to incorporate model building of protein–
ligand complexes and streamline well with the REdiii pipeline.
Applications relying on phasing methods other than mole-
cular replacement or cases requiring multiple search models
(such as protein–protein complexes) are not supported within
REdiii at this point. In such cases, the need for high-
throughput crystal screening and automation is not normally
a bottleneck, but future developments may incorporate
different phasing methods.
REdiii encompasses an entire pipeline from data processing
to refinement of ligand-bound structures without user inter-
vention and incorporates a wide range of currently used
software. In typical cases, a satisfactory solution can be
reached within a few hours using a personal computer. The
sequential workflow with intelligent decision-making allows
the software to reiterate through processes with alternative
settings and to optimize the initial setup. REdiii is highly
modular, and individual components of the pipeline can be
added or swapped easily, allowing trouble-free adaptation to a
research papers
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Table 3
Larger ensemble of ligand-bound test cases.
We used an ensemble of inhibitor-bound HIV-1 protease structures (Nalam et al., 2013).
PDB entry 3sa7 3sa6 3sa4 3sa9 3saa 3sac 3o9g 3o9d 3o9b 3o9f
Resolution (high) (A˚) 1.43 1.64 1.67 1.49 1.60 1.41 1.53 1.94 1.37 1.50
Resolution (low) (A˚) 30.83 23.51 25.48 27.12 39.27 38.24 25.11 28.80 26.21 25.10
Temperature (C) 80 80 80 80 80 80 80 80 80 80
Space group P212121 P212121 P212121 P212121 P212121 P212121 P212121 P212121 P212121 P212121
Unit-cell parameters
a (A˚) 50.93 50.84 50.96 50.73 50.85 50.88 50.70 50.77 50.64 50.72
b (A˚) 57.78 58.34 50.95 57.55 57.98 57.98 57.82 57.60 57.90 57.76
c (A˚) 61.67 61.84 61.83 61.49 61.77 61.56 61.76 61.77 61.70 61.76
Molecules in asymmetric unit 1 1 1 1 1 1 1 1 1 1
Completeness (%) 98.9 92.9 85.2 96.4 92.0 98.9 96.7 99.1 99.2 99.7
Total reflections 231305 139029 130307 212012 246459 250941 176692 88077 282140 207765
Unique reflections 33947 21470 18567 28898 57676 35375 27123 13808 38476 29607
Mean I/(I) 19.3 24.7 26.8 17.2 15.7 24.9 30.0 8.0 22.3 20.1
Average multiplicity 6.8 6.5 7.0 7.3 4.3 7.1 6.5 6.4 7.3 7.0
Rmerge 0.063 0.051 0.050 0.103 0.051 0.041 0.041 0.280 0.058 0.068
Rmeas 0.073 0.060 0.059 0.116 0.059 0.047 0.050 0.342 0.067 0.079
Rp.i.m. 0.028 0.023 0.022 0.042 0.028 0.017 0.019 0.133 0.024 0.030
CC* 0.999 0.999 0.999 0.998 0.999 1.000 1.000 0.959 1.000 0.999
Wilson B factor (A˚2) 12 15 16 13 15 15 13 19 11 13
R.m.s. deviations from ideal values
Bonds (A˚) 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01
Angles () 1.25 1.20 1.24 1.14 1.21 1.28 1.19 1.50 1.29 1.23
Average B factor (A˚2) 17 18 19 17 19 20 17 22 15 17
Ramachandran plot (%)
Favored 99 98 99 99 99 98 99 98 99 99
Allowed 0 1 1 1 1 1 1 1 1 1
Outliers 1 1 0 0 0 1 0 1 0 1
Rotamer outliers 1 0 1 0 1 0 1 1 0 1
Clashscore 7 6 5 6 4 7 6 21 5 10
R factor 0.24 0.19 0.19 0.19 0.20 0.21 0.19 0.24 0.20 0.20
Rfree 0.28 0.21 0.25 0.23 0.24 0.23 0.23 0.28 0.23 0.23
variety of needs, which is essential to accommodate the ever-
improving and changing crystallographic software environ-
ment. The modular layout in combination with the open
nature of the code should allow REdiii to become an easily
maintainable community tool for as long as there are active
users. We believe that the REdiii pipeline may be a useful
component in the crystallographic toolbox, especially in
accelerating scientific discovery through automated bio-
crystallography.
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Table 4
Larger ensemble of ligand-bound test cases.
We used an ensemble of inhibitor-bound HCV protease structures (Romano et al., 2012).
PDB code 3su2 3su1 3su0 3su6 3su5 3su4 3sv7 3sv8 3sv9 3sug
Resolution (high) (A˚) 1.27 1.19 1.19 1.19 1.32 2.04 1.46 2.20 1.43 1.70
Resolution (low) (A˚) 29.26 27.47 27.64 26.26 29.93 29.56 33.49 23.21 33.39 26.96
Space group P212121 P212121 P212121 P212121 P212121 P61 P212121 P41212 P212121 P212121
Unit-cell parameters
a (A˚) 55.10 54.95 55.28 54.96 54.87 85.86 55.31 69.57 54.69 54.06
b (A˚) 58.53 58.53 58.50 58.46 58.33 85.86 58.80 69.57 58.59 58.29
c (A˚) 60.05 59.99 60.51 59.78 59.87 97.51 60.26 78.99 60.74 62.21
Molecules in asymmetric unit 1 1 1 1 1 2 1 1 1 1
Completeness (%) 94.7 100 98.7 99.5 88.1 99.9 99.7 94.9 100 94.6
Total reflections 246782 373050 375789 356504 258979 316945 303713 133754 285413 95711
Unique reflections 49103 63075 62945 62350 39898 26025 34495 9853 36954 20988
Mean I/(I) 18.5 8.3 13.4 13.5 8.1 19.9 10.1 21.4 10.2 23.9
Average multiplicity 5.0 5.9 6.0 5.7 6.5 12.2 8.8 13.6 7.7 4.6
Rmerge 0.046 0.113 0.058 0.062 0.114 0.097 0.119 0.115 0.085 0.034
Rmeas 0.059 0.137 0.070 0.076 0.134 0.106 0.135 0.123 0.098 0.045
Rp.i.m. 0.025 0.076 0.039 0.043 0.070 0.030 0.062 0.033 0.048 0.021
CC* 0.999 0.996 0.999 0.998 0.997 0.999 0.993 0.999 0.998 1.000
Wilson B factor (A˚2) 10 11 10 8 10 26 14 23 16 23
R.m.s. deviations from ideal values
Bonds (A˚) 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01
Angles () 1.12 1.77 1.70 1.40 1.54 1.60 1.13 1.70 1.35 1.99
Average B factor (A˚2) 16 19 17 14 16 31 20 32 24 29
Ramachandran plot (%)
Favored 98 98 97 99 98 93 99 92 99 97
Allowed 2 2 3 1 1 4 1 7 1 3
Outliers 0 0 0 0 1 2 0 1 0 0
Rotamer outliers 1 0 1 1 1 3 3 6 2 1
Clashscore 7 13 10 8 8 9 5 15 9 13
R factor 0.22 0.23 0.23 0.22 0.22 0.22 0.20 0.25 0.21 0.22
Rfree 0.23 0.26 0.24 0.24 0.25 0.27 0.22 0.32 0.22 0.25
